Annual report pursuant to Section 13 and 15(d)

Asset Acquisitions - Acquisition of Emerald Health Therapeutics, Inc., Narrative (Details)

v3.24.1
Asset Acquisitions - Acquisition of Emerald Health Therapeutics, Inc., Narrative (Details) - Emerald Health Therapeutics Inc
Nov. 10, 2022
USD ($)
shares
Asset Acquisition [Line Items]  
Exchange ratio 1.95
Net assets acquired, fair value $ 15,045,412
Qualifying asset $ 1,536,275
Equity interest issued or issuable (in shares) | shares 1,665,083